Benzyl 2-(3-(acetylthio)-2-benzylpropanamido)acetate, 95.0%, 10g

5-Bromo-1H-imidazo[4,5-b]pyrazine, 97.0%, 1g

3-Bromo-4-methylpyridin-2-ol, 95.0%, 25g

2,2,2-Trifluoroethyl n-(3-chlorophenyl)carbamate, 97%, 250mg

(2R,4R)-1-(tert-Butoxycarbonyl)-4-phenoxypyrrolidine-2-carboxylic acid, 95.0%, 250mg

{2-[(4-fluorobenzoyl)amino]-1,3-thiazol-4-yl}acetic acid, 95.0%, 500mg

Adamantanol, min.99%, pour la synthèse, 250 g, emballage en verre

4-((2-fluorophenyl)sulfonamido)benzoic acid, 95.0%, 500mg

4-Vinylphenyl Acetate (stabilized with TBC)>98.0%(GC)25g

(11bR)-4-mercapto-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'f][1,3,2]dioxaphosphepin, 98%, 250mg

N,N-Dimethyl-1,3-propanediamine Dihydrobromide>98.0%(T)5g

3-Bromo-4-hydroxybenzyl alcohol, 97.0%, 100g

1-Butyl-1-methylpyrrolidinium Dicyanamide>98.0%(T)25g